Growing concern for tamoxifen

Nature Reviews Drug Discovery

Volumn 3, Issue 8, 2004, Pages 647-

  Owens, Joanna ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ANTINEOPLASTIC AGENT; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN D1; ESTROGEN RECEPTOR ALPHA; FORSKOLIN; FULVESTRANT; PROTEIN TYROSINE KINASE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; CANCER RECURRENCE; CANCER RESISTANCE; CONFORMATIONAL TRANSITION; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; NOTE; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; SIDE EFFECT;

EID: 4444325708     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd1474     Document Type: Note

References (1)

1. Michalides, R. et al. Tamoxifen resistance by a conformation arrest of the estrogen receptor α after PKA activation in breast cancer. Cancer Cell 5, 597-605 (2004)